Zalgen logo — Global Innovations. Solutions for all.

Zalgen

Global Innovations. Solutions for all.

Founded 2011 United States Frederick, United States 9 employees Biotechnology, Health Care +2

General Information

Company Name Zalgen
Founded Year 2011
Location United States Frederick, United States +2
Employees 9
Industries Biotechnology, Health Care, Health and Wellness +1
Social

Get notified when Zalgen moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Zalgen

Zalgen is a leading biotechnology company established in 2011, operating with the slogan "Global Innovations. Solutions for all." The company focuses on providing research, diagnostics, and therapeutic solutions for serious viral infectious diseases, with a specific emphasis on neglected and underrepresented diseases such as viral hemorrhagic diseases, including the Ebola virus (EBOV) and the Lassa virus (LASV). Headquartered in the United States, Zalgen has garnered attention for its expertise in addressing these often-overlooked diseases. One of Zalgen's significant pivots occurred in response to the SARS CoV-2 pandemic, where the company applied its expertise in viral infectious diseases by developing antibody tests. This strategic shift highlights the company's agility and adaptability in addressing emerging global health challenges. Zalgen's commitment to developing and deploying medical interventions to save lives aligns with the growing demand for innovative solutions in the biotechnology and health care industries. As the company continues to make strides in addressing critical viral infectious diseases, potential venture capital investors may find Zalgen's mission and expertise compelling, particularly in the context of global health priorities and the increasing need for advanced diagnostic and therapeutic solutions.

Taxonomy: Medical interventions, Viral infectious diseases, Research, Diagnostics, Therapeutic solutions, Ebola virus, Lassa virus, SARS CoV-2 pandemic, Antibody tests, Biological sciences, Global health, Innovation

No funding data available for Zalgen yet.

Get notified when Zalgen raises funding

Zalgen Alternatives & Competitors

Zalgen vs

Leading the fight against infectious diseases with advanced monoclonal antibody therapies.

Post Ipo Equity
11-50 employees
Biotechnology, Health Care
Zalgen vs

Pioneering solutions to combat serious infectious diseases with innovative therapies.

51-200 employees
Biotechnology
Zalgen vs
CaroGen Corporation
CaroGen Corporation United States

CaroGen Corporation is an emerging biopharmaceutical company with an entirely new vaccine platform t...

Grant
12 employees
Biopharma, Biotechnology

FAQ About Zalgen

Global Innovations. Solutions for all.
Zalgen was founded in 2011.
Zalgen is headquartered in Frederick, United States.
Zalgen operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences.
Zalgen has approximately 9 employees.
Top alternatives and competitors to Zalgen include Arsanis, Aviragen Therapeutics, CaroGen Corporation, Advaccine, Genelabs Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Zalgen and Arsanis are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Zalgen and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy